Bacterial cell wall and outer membrane structures

The bacterial cell wall and outer membrane structures constitute a complex, multi-layered envelope essential for bacterial survival, shape, and protection against osmotic pressure [NIH, MDPI]. In Gram-positive bacteria, this consists primarily of a thick peptidoglycan layer and teichoic acids, while Gram-negative bacteria possess a thinner peptidoglycan layer and an additional asymmetric outer membrane rich in lipopolysaccharides (LPS) and porins [NIH, Creative Biolabs]. These structures are prime therapeutic targets because they are unique to bacteria and absent in human cells, allowing for selective toxicity [NIH, Lehigh University]. Drugs like beta-lactams and glycopeptides target the synthesis and cross-linking of peptidoglycan, whereas polymyxins disrupt the outer membrane by interacting with LPS [NIH, Lumen Learning]. These components also play critical roles in pathogenesis, serving as anchors for virulence factors and acting as barriers to host immune defenses [NIH, ResearchGate]. However, the rise of multidrug-resistant (MDR) pathogens, which employ mechanisms like target modification, enzymatic degradation (e.g., beta-lactamases), and efflux pumps, presents a significant challenge to current therapies [NIH, MDPI].

Other names

Peptidoglycan (PG)Lipopolysaccharide (LPS)Outer membrane (OM)Cell envelopeTeichoic acid (TA)Penicillin-binding protein (PBP)PorinWall teichoic acid (WTA)Lipoteichoic acid (LTA)

Inhibition of peptidoglycan synthesis (transpeptidation and transglycosylation) [NIH], disruption of membrane integrity via binding to Lipid A [NIH], inhibition of lipid carrier recycling [Lumen Learning], and inhibition of early cytoplasmic cell wall precursor synthesis [MDPI].